The Institute for Medical Education & Research (IMER), an industry leading oncology continuing education company, will offer a free live broadcast of Advanced Melanoma: An Oncology Nurse Workshop on Emerging Novel Treatments, Adverse Event Management, and Patient Education. This unique event is part of the six symposia series IMER will offer during the ONS 36th Annual Congress in Boston, MA.
Advanced Melanoma: An Oncology Nurse Workshop on Emerging Novel Treatments, Adverse Event Management, and Patient Education
Wednesday, April 27, 2011 at 6:30–8:30 PM EDT
Jeannine M. Brant, PhD, APRN-CNS, AOCN® (Chairperson)
Billings Clinic Cancer Center
Peg S. Esper, MSN, MSA, RN, APRN-BC, AOCN®
University of Michigan Comprehensive Cancer Center
F. Stephen Hodi, Jr., MD
Dana-Farber Cancer Institute
The incidence of melanoma is growing rapidly in the United States but no new agents have been approved to treat the disease in 12 years. Prognosis for patients with stage III and IV disease remains poor, and there is little consensus on the standard of care. However, clinical research into new agents – eg, anti-CTLA4 antibodies, MEK inhibitors, and BRAF inhibitors – is active, and several of these compounds are being incorporated into treatment regimens. Many oncology nurses who care for patients with melanoma have already administered these new agents and have numerous questions regarding their efficacy, unique response patterns and toxicity profiles, how they may be integrated into current treatment regimens, and how to educate patients on their benefits and risks.
This symposium is intended to provide an overview of the evolving treatment options in advanced melanoma, safe novel therapy administration, and optimal side-effect management strategies.
IMER has conducted over 30 educational activities on melanoma for oncology nurses in 2010 and has collected nurse attendees’ most frequently asked questions regarding the rationale behind new treatment approaches, the safety and efficacy of emerging agents, and optimal side-effect management and response monitoring practices. In the final session of the symposium, each table will be given a question for discussion. The faculty will then review each question, obtain responses from each of these groups and provide answers. Webcast participants will interact in their own question-and-answer session and responses will be given to the faculty as well for comment.
This educational activity for 2.0 contact hours is provided by the Institute for Medical Education & Research (IMER). IMER is an approved provider of continuing nursing education by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
IMER Live Webcasts
IMER live Webcasts use advanced Internet technology to deliver the highest quality education via live or pre-recorded activities. Didactic presentations are enhanced with audience response questions, interactive discussions of challenging cases, and faculty-moderated question-and-answer sessions. Live Webcasts are complemented by access to the speakers’ downloadable slidesets and a recording of the complete virtual meeting, giving activity participants on-demand access to the content.
“Broadcasting live meetings via the Internet is a great way to virtually attend and participate in IMER conferences,” stated Ricardo Mazzi, IMER’s Director of Multimedia Services. “It caters to an audience who can not travel due to either scheduling or financial constraints. Our Web-meeting platform provides real-time interactivity for our online users with audio, video, and audience response systems.”
IMER (IMERonline.com) is an industry leader in providing accredited, independent continuing medical education (CME) / continuing education (CE) for physicians, nurses, and other health professionals who specialize in oncology. IMER offers innovative expert led accredited educational activities that translate the latest research into clinically relevant education through a variety of live, online, and print formats.
Each year IMER educates over 6,800 hematologists/oncologists and over 8,800 oncology nurses and pharmacists through 1,000 regional, local, and grand rounds activities.
Visit the website today and enhance your knowledge and skills to provide the highest level of care to patients with cancer.